Clinical aspects of systemic sclerosis (scleroderma).
作者信息
Silver R M
机构信息
Division of Immunology and Rheumatology, Medical University of South Carolina, Charleston 29425.
出版信息
Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):854-61. doi: 10.1136/ard.50.suppl_4.854.
Abstract
摘要
相似文献
1
Clinical aspects of systemic sclerosis (scleroderma).系统性硬化症（硬皮病）的临床方面
Ann Rheum Dis. 1991 Nov;50 Suppl 4(Suppl 4):854-61. doi: 10.1136/ard.50.suppl_4.854.
2
Progressive systemic sclerosis (scleroderma).
Australas Ann Med. 1970 May;19(2):145-50. doi: 10.1111/imj.1970.19.2.145.
3
Scleroderma. 2. Incidence of systemic disturbance and assessment of possible aetiological factors.硬皮病。2. 全身症状的发生率及可能病因因素的评估。
Med J Aust. 1969 May 17;1(20):1040-7. doi: 10.5694/j.1326-5377.1969.tb49876.x.
4
Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.
Ann Intern Med. 1971 Sep;75(3):369-76. doi: 10.7326/0003-4819-75-3-369.
5
Scleroderma and scleroderma-like disorders.硬皮病及硬皮病样疾病
Semin Arthritis Rheum. 1986 Aug;16(1):22-69. doi: 10.1016/0049-0172(86)90040-5.
6
Sentinel signs and symptoms of systemic sclerosis.
Curr Opin Rheumatol. 1989 Dec;1(4):499-504. doi: 10.1097/00002281-198901040-00014.
7
Severe organ involvement in systemic sclerosis with diffuse scleroderma.系统性硬化症伴弥漫性硬皮病的严重器官受累。
Arthritis Rheum. 2000 Nov;43(11):2437-44. doi: 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U.
8
Raynaud's phenomenon and scleroderma.雷诺现象与硬皮病。
Compr Ther. 1981 Feb;7(2):45-51.
9
[The Thibierge-Wessenbach syndrome].[蒂比耶热 - 韦森巴赫综合征]
Med Interna (Bucur). 1973 Jun;25(6):733-41.
10
Familial scleroderma.家族性硬皮病。
Br J Dermatol. 1974 Nov;91(5):517-22. doi: 10.1111/j.1365-2133.1974.tb12939.x.
引用本文的文献
1
Effects of a Self-Management Telehealth Program on Improving Strength and Hand Function in Systemic Sclerosis Patients: A Randomized Controlled Trial.一项自我管理远程医疗计划对改善系统性硬化症患者力量和手部功能的影响：一项随机对照试验。
Life (Basel). 2025 Jul 10;15(7):1087. doi: 10.3390/life15071087.
2
Pigmentary Changes in Systemic Sclerosis are Associated with More Severe Cutaneous Sclerosis and Severity of Other Systems: A Cross-sectional Study from India.系统性硬化症的色素沉着变化与更严重的皮肤硬化及其他系统的严重程度相关：一项来自印度的横断面研究
Indian J Dermatol. 2024 Jul-Aug;69(4):365. doi: 10.4103/ijd.ijd_251_24. Epub 2024 Aug 19.
3
A Positive Feedback Loop Exists between Estradiol and IL-6 and Contributes to Dermal Fibrosis.雌二醇和白细胞介素-6 之间存在正反馈环，导致皮肤纤维化。
Int J Mol Sci. 2024 Jun 30;25(13):7227. doi: 10.3390/ijms25137227.
4
Calcinosis Prevalence in Autoimmune Connective Tissue Diseases-A Retrospective Study.自身免疫性结缔组织病中钙质沉着症的患病率——一项回顾性研究
J Clin Med. 2024 Jun 12;13(12):3428. doi: 10.3390/jcm13123428.
5
Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis.非裔美国系统性硬化症患者经典单核细胞中独特的全基因组 DNA 甲基化和基因表达特征。
Clin Epigenetics. 2023 Feb 17;15(1):25. doi: 10.1186/s13148-023-01445-5.
6
Myofibroblast specific targeting approaches to improve fibrosis treatment.肌成纤维细胞特异性靶向治疗改善纤维化。
Chem Commun (Camb). 2022 Dec 8;58(98):13556-13571. doi: 10.1039/d2cc04825f.
7
Development and validation of machine learning for early mortality in systemic sclerosis.系统性硬皮病早期死亡的机器学习开发与验证。
Sci Rep. 2022 Oct 13;12(1):17178. doi: 10.1038/s41598-022-22161-9.
8
Association between CA 15‑3 and progression of interstitial lung disease in a case of coexisting systemic sclerosis and recurrent breast cancer: A case report.15-3 糖类抗原与系统性硬化症合并复发性乳腺癌患者间质性肺疾病进展的相关性：一例报告
Mol Clin Oncol. 2022 Aug 8;17(4):145. doi: 10.3892/mco.2022.2578. eCollection 2022 Oct.
9
Skin thickness affects the result of tuberculin skin test in systemic sclerosis.皮肤厚度会影响系统性硬化症患者结核菌素皮肤试验的结果。
BMC Rheumatol. 2022 Aug 13;6(1):48. doi: 10.1186/s41927-022-00278-8.
10
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay.结缔组织病相关肺部疾病的临床及影像学特征：图文综述
Insights Imaging. 2022 Jun 29;13(1):108. doi: 10.1186/s13244-022-01243-2.
本文引用的文献
1
Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis.早期进行性系统性硬化症中肺血管动力学和炎症的异常
Arthritis Rheum. 1981 Nov;24(11):1403-8. doi: 10.1002/art.1780241111.
2
A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report.雷诺现象与早期结缔组织病的前瞻性研究。一份五年报告。
Am J Med. 1982 Jun;72(6):883-8. doi: 10.1016/0002-9343(82)90846-4.
3
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.在使用L-5-羟色氨酸和卡比多巴治疗期间出现硬皮病样疾病。
N Engl J Med. 1980 Oct 2;303(14):782-7. doi: 10.1056/NEJM198010023031403.
4
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.硬皮病和雷诺现象中因子VIII/血管性血友病因子抗原及血管性血友病因子活性增加。
Ann Intern Med. 1981 Apr;94(4 pt 1):482-4. doi: 10.7326/0003-4819-94-4-482.
5
HLA antigens, autoantibodies and clinical subsets in scleroderma.硬皮病中的人类白细胞抗原、自身抗体及临床亚组
Br J Rheumatol. 1984 Nov;23(4):267-71. doi: 10.1093/rheumatology/23.4.267.
6
Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.硬皮病中的间质性肺疾病。经支气管肺泡灌洗分析
Arthritis Rheum. 1984 Nov;27(11):1254-62. doi: 10.1002/art.1780271107.
7
Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.尽管使用卡托普利使血压正常化，但硬皮病高血压患者的肾功能仍会恶化。
Klin Wochenschr. 1984 Aug 1;62(15):728-30. doi: 10.1007/BF01725706.
8
Factors predicting development of renal involvement in progressive systemic sclerosis.预测进行性系统性硬化症肾脏受累发展的因素。
Am J Med. 1984 May;76(5):779-86. doi: 10.1016/0002-9343(84)90986-0.
9
Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders.
Am J Med. 1984 Nov;77(5):812-22. doi: 10.1016/0002-9343(84)90517-5.
10
Lung involvement in scleroderma.硬皮病中的肺部受累
Chest. 1984 Mar;85(3):318-24. doi: 10.1378/chest.85.3.318.
Zotero 插件